All times are in Central European Time (CET).
If you need another time zone, this website might be useful to you: https://www.worldtimebuddy.com/
All times are in Central European Time (CET).
If you need another time zone, this website might be useful to you: https://www.worldtimebuddy.com/
The high rates of antiretroviral success and the increasingly healthy, although aging, HIV population, have led to the development of new strategies for providing ongoing HIV care. These changes in the provision of care have been accelerated through need. Secondary to the recent COVID-19 pandemic with a move from standard regular face-to-face consultation to a greater reliance on telemedicine and virtual clinics.
Whilst this move away from clinic visits may be suitable for those some, the correct strategies are yet to be discerned and are likely to need individualization both in the clinical setting as well as the individual patient.
It is unlikely that one size will fit all, and different groups affected by HIV are likely to require different plans. There will also be the issue of providing care for those with co-morbidities which may shift towards the primary care setting.
As new formulations are likely to be approved and be made available shortly, including intramuscular injections and sustained release delivery through other routes, the most optimal method for the delivery of these medications for either treatment or prevention will need to be discussed among various healthcare professionals involved in clinical care.
The route from research to clinical implementation is a “bumpy road” resulting in most novel approaches not reaching the clinic. Potential reasons for this are a misfit between the research setting and real-life practice, policy/regulatory barriers, and importantly a mismatch in the preference of the stakeholder.
Working together with all stakeholders and engaging the clients in utilizing implementation strategies is needed to improve the delivery of evidence-based novel interventions.
This program brought together all those who are involved in the implementation of novel strategies to improve the health care for people living with HIV resulting in an improved quality of life. By discussing the barriers but also the challenges together, we aim at more successful implementation of innovations.
The Implementation Science & Innovations in HIV Care 2022 is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.